Targeting outflow facility in glaucoma management

Survey of Ophthalmology

Volumn 48, Issue 2 SUPPL. 1, 2003, Pages

  Brubaker, Richard F ^a  

^a MAYO CLINIC   (United States)

Author keywords

Glaucoma; Intraocular pressure; Outflow; Tonography

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIMATOPROST; BRIMONIDINE; CARBONATE DEHYDRATASE INHIBITOR; CATECHOLAMINE; DORZOLAMIDE; LATANOPROST; PILOCARPINE; TIMOLOL; ANTIHYPERTENSIVE AGENT; MIOTIC AGENT;

AQUEOUS HUMOR; AQUEOUS HUMOR FORMATION; AQUEOUS HUMOR OUTFLOW; CIRCADIAN RHYTHM; DRUG MECHANISM; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; DRUG EFFECT; SECRETION;

ANTIHYPERTENSIVE AGENTS; AQUEOUS HUMOR; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MIOTICS;

EID: 3142656505     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6257(03)00003-1     Document Type: Article

References (21)

1. Asrani S, Zeimer R, Wilensky J, et al: Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma 9:134-42, 2000
2. Becker B, Shaffer RN: Diagnosis and therapy of the glaucomas. St Louis, Missouri, Mosby, 1965 (ed 2), pp 54-6
3. Brown B, Burton P, Mann S, Parisi A: Fluctuations in intraocular pressure with sleep: II. Time course of IOP decrease after waking from sleep. Ophthalmic Physiol Opt 8:249-52, 1988
4. Brubaker R: Measurement of uveoscleral outflow in humans. J Glaucoma 10(Suppl 1):S45-8, 2001
5. Brubaker RF: Mechanism of action of bimatoprost (Lumigan). Surv Ophthalmol 45(Suppl 4):S347-51, 2001
6. Brubaker RF, Schoff EO, Nau CB, et al: Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics. Am J Ophthalmol 131:19-24, 2001
7. Ellingsen BA, Grant WM: The relationship of pressure and aqueous outflow in enucleated human eyes. Invest Ophthalmol 10:430-7, 1971
8. Erickson-Lamy KA, Nathanson JA: Epinephrine increases facility of outflow and cyclic AMP content in the human eye in vitro. Invest Ophthalmol Vis Sci 33:2672-8, 1992
9. Gharagozloo NZ, Relf SJ, Brubaker RF: Aqueous flow is reduced by the alpha-adrenergic agonist, apraclonidine hydrochloride (ALO 2145). Ophthalmology 95:1217-20, 1988
10. Grant WM: Clinical measurements of aqueous outflow. Arch Ophthalmol 46:113-31, 1951
11. Heijl A, Leske MC, Bengtsson B, et al: Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120:1268-79, 2002
12. Johnson DH, Tschumper RC: Human trabecular meshwork organ culture. A new method. Invest Ophthalmol Vis Sci 28:945-53, 1987
13. Kaufman PL, Bárány EH: Loss of acute pilocarpine effect on outflow facility following surgical disinsertion and retrodisplacement of the ciliary muscle from the scleral spur in the cynomolgus monkey. Invest Ophthalmol 15:793-807, 1976
14. Saito M, Takano R, Shirato S: Effects of latanoprost and unoprostone when used alone or in combination for open-angle glaucoma. Am J Ophthalmol 132:485-9, 2001
15. Sakurai M, Araie M, Oshika T, et al: Effects of topical application of UF-021, a novel prostaglandin derivative, on aqueous humor dynamics in normal human eyes. Jpn J Ophthalmol 35:156-65, 1991
16. Topper JE, Brubaker RF: Effects of timolol, epinephrine, and acetazolamide on aqueous flow during sleep. Invest Ophthalmol Vis Sci 26:1315-9, 1985
17. Toris CB, Camras CB, Yablonski ME: Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients. Am J Ophthalmol 128:8-14, 1999
18. Toris CB, Camras CB, Yablonski ME: Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes. Ophthalmology 100:1297-304, 1993
19. Toris CB, Zhan GL, Zhao J, et al: Potential mechanism for the additivity of pilocarpine and latanoprost. Am J Ophthalmol 131:722-8, 2001
20. Yablonski ME, Zimmerman TJ, Waltman SR, Becker B: A fluorophotometric study of the effect of topical timolol on aqueous humor dynamics. Exp Eye Res 27:135-42, 1978
21. Ziai N, Dolan JW, Kacere RD, Brubaker RF: The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes. Arch Ophthalmol 11:1351-8, 1993